Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options
Key Highlights
- ➤Arcutis (ARQT) launches Skin to Believe In campaign with Simone Biles.
- ➤ZORYVE foam 0.3% delivered 77% clear or almost clear skin after eight weeks.
- ➤ZORYVE cream 0.15% delivered 31% clear or almost clear skin at four weeks.
- ➤ZORYVE is the #1 prescribed branded topical therapy across three inflammatory dermatoses.
Expert Statements
Simone Biles, World Champion gymnast
“A couple of years ago I started noticing flakes and itching on my scalp — especially on the crown of my head. At first, I thought it was a lot of dandruff, then I worried it might be something contagious. I also had patches of dry, itchy skin that kept appearing on my arms, and I wondered if the two were related. I tried over-the-counter products like shampoos and creams, but those didn’t work for me.”
Simone Biles, World Champion gymnast
“Dealing with flakes in my hair was frustrating and made me feel uncomfortable, so I spoke with my dermatologist who diagnosed me with seborrheic dermatitis on my face and scalp and eczema on my arms. She recommended ZORYVE foam for my seborrheic dermatitis and ZORYVE cream for my eczema. I like ZORYVE because it is not a steroid, pill, injection, or shampoo and it's easy to use, not greasy, and fits into my routine. Using ZORYVE reduced the flakes and itching on my scalp, which bothered me the most, and the eczema spots on my arms are also clearer, too.”
Angela J. Lamb, Board-certified dermatologist
“For years, conditions like seborrheic dermatitis and eczema could require multiple treatments, complex application schedules, and cycles of on and off use due to the limitations of the treatments. Now, we have access to innovative prescription treatments like ZORYVE that target the underlying inflammation driving these conditions, allowing us to improve symptoms.”
Angela J. Lamb, Board-certified dermatologist
“ZORYVE is a once-daily, steroid-free PDE4 inhibitor available in both foam and cream formulations that are non-greasy and don’t contain harmful ingredients that can disrupt the skin barrier. Finding solutions that can be used anywhere on the skin and continuously for any duration are important for long-term management of these chronic skin conditions.”
Frank Watanabe, President and CEO of Arcutis
“As one of the most recognized athletes in the world, Simone Biles understands the significant challenges of living with a visible skin condition. By sharing her story, she is helping to empower others to take control of their skin health by speaking with their healthcare provider about advanced, targeted treatment options like ZORYVE. This awareness campaign reinforces Arcutis’ commitment to delivering innovative therapies for inflammatory skin conditions, including seborrheic dermatitis and eczema, with flexible solutions designed to meet patients’ needs from head to toe.”
Simone Biles, World Champion gymnast
“I’ve learned that we can’t fix every problem on our own and it’s OK to seek help. I believe how you care for yourself reflects how you carry yourself, and by partnering with Arcutis on this awareness campaign I believe we can break the stigma associated with chronic skin conditions by helping people feel empowered to speak with a healthcare provider about their symptoms so that they can find a treatment that works for them.”
* Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin health * Biles’ treatment, ZORYVE(®) (roflumilast), is the #1 prescribed branded topical therapy for three major inflammatory skin conditions combined — seborrheic dermatitis, eczema, and plaque psoriasis WESTLAKE VILLAGE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that World Champion gymnast Simone Biles has partnered with the company to launch its Skin to Believe In awareness campaign. The campaign encourages the approximately 36 million Americans living with inflammatory skin conditions, such as seborrheic dermatitis and atopic dermatitis (the most common form of eczema), to talk with their doctor about long-term, steroid-free, topical treatment options for their chronic skin diseases.
Get started
Create a free account to read the full story.
